{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:50:26Z","timestamp":1775645426695,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":1173,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1111\/ajt.15352","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T12:15:49Z","timestamp":1552392949000},"page":"2570-2582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3140-9530","authenticated-orcid":false,"given":"Danae","family":"Bixler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-8785","authenticated-orcid":false,"given":"Pallavi","family":"Annambholta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston E.","family":"Abara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-8123","authenticated-orcid":false,"given":"Melissa G.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4974-9058","authenticated-orcid":false,"given":"Jefferson","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonya","family":"Mixson-Hayden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridhar V.","family":"Basavaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumathi","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleem","family":"Kamili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2411-2798","authenticated-orcid":false,"given":"Anne","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.15352_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.1840130402","article-title":"Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease","volume":"13","author":"Todo","year":"1991","journal-title":"Hepatology."},{"key":"10.1111\/ajt.15352_bib2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","article-title":"Liver transplantation in European patients with the hepatitis B surface antigen","volume":"329","author":"Samuel","year":"1993","journal-title":"N Engl J Med."},{"issue":"Suppl 1","key":"10.1111\/ajt.15352_bib3","first-page":"1","article-title":"Introduction to hepatitis B transplantation","volume":"20","author":"Vierling","year":"2000","journal-title":"Semin Liver Dis."},{"key":"10.1111\/ajt.15352_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.idc.2018.04.010","article-title":"Management of viral hepatitis in solid organ transplant recipients","volume":"32","author":"Buganza-Torio","year":"2018","journal-title":"Infect Dis Clin North Am."},{"key":"10.1111\/ajt.15352_bib5","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/jama.296.15.1843","article-title":"Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients","volume":"296","author":"Gasink","year":"2006","journal-title":"JAMA."},{"key":"10.1111\/ajt.15352_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00430-009-0131-8","article-title":"Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation","volume":"199","author":"Peveling-Oberhag","year":"2010","journal-title":"Med Microbiol Immunol."},{"issue":"35","key":"10.1111\/ajt.15352_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.healun.2015.10.012","article-title":"Impact of donor and recipient hepatitis C status in lung transplantation","volume":"2016","author":"Englum","year":"2016","journal-title":"J Heart Lung Transplant."},{"key":"10.1111\/ajt.15352_bib8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/TP.0b013e3181bd3e59","article-title":"Impact of hepatitis C infection on outcomes after heart transplantation","volume":"88","author":"Fong","year":"2009","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15352_bib9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/lt.21784","article-title":"The natural history of hepatitis C cirrhosis after liver transplantation","volume":"15","author":"Firpi","year":"2009","journal-title":"Liver Transpl."},{"issue":"4","key":"10.1111\/ajt.15352_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/egh.10.39","article-title":"Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression","volume":"4","author":"Maluf","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"10.1111\/ajt.15352_bib11","unstructured":"American Association for the Study of Liver Disease (AASLD) and Infectious Disease Society of America (IDSA). HCV guidance: recommendations for testing, managing, and treating hepatitis C, updated May 24, 2018. https:\/\/www.hcvguidelines.org\/. Accessed August 20, 2018."},{"issue":"2","key":"10.1111\/ajt.15352_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/M16-1205","article-title":"Treatment with ledipasvir-sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial","volume":"166","author":"Colombo","year":"2017","journal-title":"Ann Intern Med."},{"issue":"21","key":"10.1111\/ajt.15352_bib13","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1056\/NEJMc1611829","article-title":"Perioperative ledipasvir-sofosbuvir for HCV in liver-transplant recipients","volume":"375","author":"Levitsky","year":"2016","journal-title":"N Engl J Med."},{"issue":"24","key":"10.1111\/ajt.15352_bib14","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1111\/ajt.15352_bib15","doi-asserted-by":"crossref","first-page":"e13308","DOI":"10.1111\/ctr.13308","article-title":"Accepting hepatitis C virus-infected donor hearts for transplantation: multistep consent, unrealized opportunity, and the Stanford experience","volume":"11","author":"Moayedi","year":"2018","journal-title":"Clin Transplant."},{"key":"10.1111\/ajt.15352_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C\u2013infected kidneys into uninfected recipients: a single-group trial","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med."},{"issue":"10","key":"10.1111\/ajt.15352_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States \u2013 a national registry study","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med."},{"issue":"4","key":"10.1111\/ajt.15352_bib18","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.29572","article-title":"The rise of the opioid epidemic and hepatitis C-positive organs: a new era in liver transplantation","volume":"67","author":"Gonzalez","year":"2018","journal-title":"Hepatology."},{"issue":"3","key":"10.1111\/ajt.15352_bib19","first-page":"61","article-title":"Trends in deceased solid organ donor characteristics and hepatitis B, C, and HIV screening results in the opioid epidemic era\u2014United States, 2010\u20132017","volume":"68","author":"Abara","year":"2019","journal-title":"MMWR."},{"issue":"32","key":"10.1111\/ajt.15352_bib20","first-page":"1087","article-title":"Notes from the field: Transplant-transmitted hepatitis B virus -- United States, 2010.","volume":"60","year":"2011","journal-title":"MMWR."},{"issue":"13","key":"10.1111\/ajt.15352_bib21","first-page":"273","article-title":"Hepatitis C virus transmission from an antibody-negative organ and tissue donor\u2013United States, 2000-2002","volume":"52","year":"2003","journal-title":"MMWR."},{"issue":"9","key":"10.1111\/ajt.15352_bib22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.7326\/0003-4819-143-9-200511010-00008","article-title":"Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor","volume":"143","author":"Tugwell","year":"2005","journal-title":"Ann Intern Med."},{"issue":"50","key":"10.1111\/ajt.15352_bib23","first-page":"1697","article-title":"Transmission of hepatitis C virus through transplanted organs and tissue\u2014Kentucky and Massachusetts, 2011","volume":"60","year":"2011","journal-title":"MMWR."},{"issue":"6","key":"10.1111\/ajt.15352_bib24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1600-6143.2011.03597.x","article-title":"Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.15352_bib25","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/ajt.13283","article-title":"Transmission of hepatitis C virus from organ donors despite nucleic acid test screening","volume":"15","author":"Suryaprasad","year":"2015","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15352_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/003335491312800403","article-title":"PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation","volume":"128","author":"Seem","year":"2013","journal-title":"Public Health Rep."},{"key":"10.1111\/ajt.15352_bib27","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1600-6143.2011.03460.x","article-title":"Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis","volume":"11","author":"Kucirka","year":"2011","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15352_bib28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1600-6143.2010.03329.x","article-title":"Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis","volume":"11","author":"Kucirka","year":"2011","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15352_bib29","doi-asserted-by":"crossref","first-page":"9658904","DOI":"10.1155\/2016\/9658904","article-title":"Utilization of Public Health Service increased risk donors yields equivalent outcomes in liver transplantation","volume":"2016","author":"Fleetwood","year":"2016","journal-title":"J Transplant."},{"issue":"7","key":"10.1111\/ajt.15352_bib30","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/TP.0000000000001716","article-title":"Deceased organ donors and PHS risk identification: impact on organ usage and outcomes","volume":"101","author":"Pruett","year":"2017","journal-title":"Transplantation."},{"issue":"3","key":"10.1111\/ajt.15352_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/ajt.14577","article-title":"Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys","volume":"18","author":"Bowring","year":"2018","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15352_bib32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/lt.25009","article-title":"What are the outcomes of declining a Public Health Service increased risk liver donor for patients on the liver transplant waiting list?","volume":"24","author":"Croome","year":"2018","journal-title":"Liver Transplant."},{"key":"10.1111\/ajt.15352_bib33","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/TP.0000000000001673","article-title":"The \u201cPHS increased risk\u201d label is associated with nonutilization of hundreds of organs per year","volume":"101","author":"Volk","year":"2017","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15352_bib34","first-page":"297","article-title":"HIV transmitted from a living organ donor\u2014New York City, 2009","volume":"60","year":"2011","journal-title":"MMWR."},{"key":"10.1111\/ajt.15352_bib35","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.4269\/ajtmh.14-0068","article-title":"Hepatitis B virus and hepatitis C virus infections in United States-bound refugees from Asia and Africa","volume":"90","author":"Mixson-Hayden","year":"2014","journal-title":"Am J Trop Med Hyg."},{"issue":"suppl 10","key":"10.1111\/ajt.15352_bib36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1186\/s12864-017-4267-4","article-title":"Transmissibility of intra-host hepatitis C virus variants","volume":"18","author":"Campo","year":"2017","journal-title":"BMC Genom."},{"key":"10.1111\/ajt.15352_bib37","doi-asserted-by":"crossref","first-page":"e13022","DOI":"10.1111\/ctr.13022","article-title":"Allograft transmission of hepatitis C during the window period: weighing the new risks and costs in the era of donor shortage","volume":"31","author":"Choe","year":"2017","journal-title":"Clin Transplant."},{"key":"10.1111\/ajt.15352_bib38","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology."},{"issue":"11","key":"10.1111\/ajt.15352_bib39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/M17-0377","article-title":"Hepatitis B virus reactivation associated with direct-acting antiviral therapy for chronic hepatitis C virus: a review of cases reported to the U.S. Food and Drug Administration Adverse Event Reporting System","volume":"166","author":"Bersoff-Matcha","year":"2017","journal-title":"Ann Intern Med."},{"issue":"1","key":"10.1111\/ajt.15352_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute Guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Reddy","year":"2015","journal-title":"Gastroenterology."},{"key":"10.1111\/ajt.15352_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1651-2227.2006.00180.x","article-title":"Understanding diagnostic tests 1: sensitivity, specificity and predictive values","volume":"96","author":"Akobeng","year":"2007","journal-title":"Acta Paediatr."},{"key":"10.1111\/ajt.15352_bib42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1600-6143.2009.02992.x","article-title":"Nucleic acid testing (NAT) of organ donors: is the \u2018best\u2019 test the right test? A consensus conference report","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15352_bib43","first-page":"47","article-title":"Increases in acute hepatitis B virus infections\u2014Kentucky, Tennessee, and West Virginia, 2006-2013","volume":"65","author":"Harris","year":"2016","journal-title":"MMWR."},{"issue":"2","key":"10.1111\/ajt.15352_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am J Public Health."},{"key":"10.1111\/ajt.15352_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014-2015","volume":"375","author":"Peters","year":"2016","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1111\/ajt.15352_bib46","first-page":"253","article-title":"Increase in HIV diagnoses among persons who inject drugs\u2014Northeastern Massachusetts, 2015-2018","volume":"68","author":"Cranston","year":"2019","journal-title":"MMWR."},{"issue":"2","key":"10.1111\/ajt.15352_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0033-1345717","article-title":"The molecular virology of hepatitis B virus","volume":"33","author":"Glebe","year":"2013","journal-title":"Semin Liver Dis."},{"issue":"1 suppl","key":"10.1111\/ajt.15352_bib48","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jhep.2014.06.031","article-title":"Virology and cell biology of the hepatitis C virus life cycle\u2014an update","volume":"61","author":"Dubuisson","year":"2014","journal-title":"J Hepatol."},{"issue":"suppl 1","key":"10.1111\/ajt.15352_bib49","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/cid\/cis368","article-title":"Laboratory diagnostics for hepatitis C virus infection","volume":"55","author":"Kamili","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1111\/ajt.15352_bib50","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fimmu.2014.00274","article-title":"Protective immunity against hepatitis C: many shades of gray","volume":"5","author":"Abdel-Hakeem","year":"2014","journal-title":"Front Immunol."},{"key":"10.1111\/ajt.15352_bib51","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/infdis\/jiv220","article-title":"Hepatitis C virus reinfection and spontaneous clearance of reinfection\u2013the InC3 study","volume":"212","author":"Sacks-Davis","year":"2015","journal-title":"J Infect Dis."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15352","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15352","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15352","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522092322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522092322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:25:09Z","timestamp":1761629109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522092322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1600613522092322"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15352","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}